Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Cancer pharmacogenomics in children: research initiatives and progress to date.

Rassekh SR, Ross CJ, Carleton BC, Hayden MR.

Paediatr Drugs. 2013 Apr;15(2):71-81. doi: 10.1007/s40272-013-0021-9. Review.

PMID:
23529868
2.

Pharmacogenomics of serious adverse drug reactions in pediatric oncology.

Ross CJ, Visscher H, Rassekh SR, Castro-Pastrana LI, Shereck E, Carleton B, Hayden MR.

J Popul Ther Clin Pharmacol. 2011;18:e134-51. Epub 2011 Mar 21. Review.

3.

Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.

Robaey P, Krajinovic M, Marcoux S, Moghrabi A.

Dev Disabil Res Rev. 2008;14(3):211-20. doi: 10.1002/ddrr.29. Review.

PMID:
18924160
4.

Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.

Wouters KA, Kremer LC, Miller TL, Herman EH, Lipshultz SE.

Br J Haematol. 2005 Dec;131(5):561-78. Review.

PMID:
16351632
5.
6.

Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model.

Goetz MP, Ames MM, Weinshilboum RM.

Mayo Clin Proc. 2004 Mar;79(3):376-84. Review.

PMID:
15008610
7.

Pharmacogenomics in pediatric leukemia.

Paugh SW, Stocco G, Evans WE.

Curr Opin Pediatr. 2010 Dec;22(6):703-10. doi: 10.1097/MOP.0b013e32833fde85. Review.

8.

Pharmacogenomics of cancer chemotherapy-induced toxicity.

Miller CR, McLeod HL.

J Support Oncol. 2007 Jan;5(1):9-14. Review.

PMID:
17265780
9.

Cancer chemotherapy in infants and children.

Bleyer WA.

Pediatr Clin North Am. 1985 Jun;32(3):557-74. Review.

PMID:
2582342
10.

Pharmacogenomics of childhood acute lymphoblastic leukemia.

Brenner TL, Pui CH, Evan WE.

Curr Opin Mol Ther. 2001 Dec;3(6):567-78. Review.

PMID:
11804271
11.

Comparative pharmacogenomics of antiretroviral and cytotoxic treatments.

Stebbing J, Bower M.

Lancet Oncol. 2006 Jan;7(1):61-8. Review.

PMID:
16389185
12.

Pharmacogenomics of sex difference in chemotherapeutic toxicity.

Wang J, Huang Y.

Curr Drug Discov Technol. 2007 Jun;4(1):59-68. Review.

PMID:
17630929
13.

Pharmacogenetics and pediatric cancer.

Bomgaars L, McLeod HL.

Cancer J. 2005 Jul-Aug;11(4):314-23. Review.

PMID:
16197721
15.

Genomics and pharmacogenomics of pancreatic adenocarcinoma.

Lowery MA, O'Reilly EM.

Pharmacogenomics J. 2012 Feb;12(1):1-9. doi: 10.1038/tpj.2011.52. Epub 2011 Dec 20. Review.

PMID:
22186617
16.

Cancer pharmacogenomics: strategies and challenges.

Wheeler HE, Maitland ML, Dolan ME, Cox NJ, Ratain MJ.

Nat Rev Genet. 2013 Jan;14(1):23-34. doi: 10.1038/nrg3352. Epub 2012 Nov 27. Review.

17.

Pharmacogenomics of pediatric acute lymphoblastic leukemia.

Meeker ND, Yang JJ, Schiffman JD.

Expert Opin Pharmacother. 2010 Jul;11(10):1621-32. doi: 10.1517/14656566.2010.484019. Review.

PMID:
20429672
18.

Somatic pharmacogenomics in cancer.

Ikediobi ON.

Pharmacogenomics J. 2008 Oct;8(5):305-14. doi: 10.1038/tpj.2008.8. Epub 2008 Aug 5. Review.

PMID:
18679398
19.

Germline pharmacogenomics in oncology: decoding the patient for targeting therapy.

O'Donnell PH, Ratain MJ.

Mol Oncol. 2012 Apr;6(2):251-9. doi: 10.1016/j.molonc.2012.01.005. Epub 2012 Jan 21. Review.

20.

Update on pharmacogenetics in cancer chemotherapy.

Innocenti F, Ratain MJ.

Eur J Cancer. 2002 Mar;38(5):639-44. Review.

PMID:
11916544
Items per page

Supplemental Content

Write to the Help Desk